Profile data is unavailable for this security.
About the company
MeCure Industries Plc is a human therapeutics company. The Company is principally in the business of manufacturing pharmaceutical products, distribution of pharmaceutical and multivitamin products. Its manufactures drugs in Nigeria under two categories namely pharmaceuticals and nutraceuticals. It produces and markets affordable generic drugs as well as innovative and specialty pharmaceuticals. The Company’s products include OTC Medicine, Branded Generics, and Dietary Supplements. Its OTC medicine provides branded products that are intended to prevent illness and promote well-being. Its branded generic provides exceptional integration of generics enables to generate a robust pipeline of high-value medicines, with an emphasis on branded generics, and includes tablets, capsules, liquids. Its manufacturing facility is in Oshodi Lagos.
- Revenue in NGN (TTM)40.40bn
- Net income in NGN2.48bn
- Incorporated2005
- Employees137.00
- LocationMeCure Industries PLCMe Cure House, Apapa-OshodiLAGOS 102215NigeriaNGA
- Websitehttp://www.mecure.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Modern Chinese Medicine Group Co Ltd | 55.94bn | 3.34bn | 51.16bn | 190.00 | 15.32 | 0.4716 | 10.69 | 0.9146 | 0.0258 | 0.0258 | 0.4319 | 0.8375 | 0.482 | 5.62 | 4.48 | 1,356,694.00 | 2.88 | 20.76 | 3.08 | 25.82 | 27.70 | 41.02 | 5.97 | 20.11 | 10.90 | -- | 0.001 | 2.54 | -13.91 | 14.67 | -44.44 | 0.2303 | 96.96 | -- |
| B.M.P. Pharma Trading AG | -176.90tn | -176.90tn | 51.24bn | 45.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 16.68 | -- | 17.58 | -- | 0.2347 | -- | 87,097.18 | -- | -- | -- | -- | -96.34 | -61.60 | 75.39 | 43.01 | -- | -- |
| Mecure Industries PLC | 40.40bn | 2.48bn | 51.80bn | 137.00 | 20.85 | 3.93 | 10.19 | 1.28 | 0.6212 | 0.6212 | 10.10 | 3.30 | 0.9412 | 3.09 | 23.80 | -- | 5.79 | 6.88 | 7.41 | 7.96 | 31.78 | 32.89 | 6.15 | 6.37 | 0.4549 | 1.98 | 0.7099 | -- | 19.21 | 15.92 | 11.66 | 46.79 | 35.17 | -- |
| Dare Bioscience Inc | 4.77bn | -12.10bn | 52.06bn | 23.00 | -- | 11.40 | -- | 10.91 | -1.07 | -1.07 | 0.3579 | 0.3126 | 0.1213 | -- | 3.85 | 123,462.20 | -30.76 | -109.51 | -191.39 | -246.26 | 0.8477 | -- | -253.60 | -1,104.55 | -- | -- | 0.00 | -- | -71.92 | -- | 2.54 | -- | 121.37 | -- |
| KALA BIO Inc | 0.00 | -65.45bn | 52.32bn | 43.00 | -- | 4.54 | -- | -- | -12.47 | -12.47 | 0.00 | 1.49 | 0.00 | -- | -- | 0.00 | -67.64 | -57.83 | -96.17 | -69.32 | -- | 57.06 | -- | -1,553.61 | -- | -11.21 | 0.8367 | -- | -100.00 | -- | 5.85 | -- | -17.31 | -- |
| Jack Chia Industries Thailand PCL | 43.31bn | 4.13bn | 52.50bn | 136.00 | 12.72 | 0.8049 | 10.44 | 1.21 | 6.37 | 6.37 | 66.82 | 100.64 | 0.5816 | 1.93 | 4.39 | 6,632,517.00 | 5.54 | 5.61 | 5.94 | 6.08 | 41.02 | 41.15 | 9.53 | 10.15 | 5.84 | 9.83 | 0.00 | 64.50 | 18.30 | 1.51 | 7.59 | 1.19 | -9.91 | 0.237 |
| Inoviq Ltd | 858.30m | -7.11bn | 52.60bn | 85.00 | -- | 2.30 | -- | 61.28 | -0.0709 | -0.0709 | 0.0086 | 0.1894 | 0.0366 | 4.54 | 0.6418 | -- | -30.33 | -44.62 | -32.64 | -47.55 | 89.77 | -- | -827.88 | -1,928.52 | 7.06 | -- | 0.0198 | -- | 5.29 | 146.33 | 26.92 | -- | -- | -- |
| Orexo AB | 90.99bn | -16.08bn | 52.95bn | 113.00 | -- | -- | -- | 0.582 | -3.05 | -3.05 | 17.28 | -0.7896 | 0.7609 | 1.17 | 2.32 | 5,136,207.00 | -13.45 | -6.41 | -20.81 | -9.99 | 88.28 | 86.76 | -17.67 | -11.83 | 1.47 | -0.7557 | 1.05 | -- | 2.32 | -3.99 | 27.76 | -- | 25.77 | -- |
